These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 16000892)

  • 21. Treatment of long, diffuse in-stent restenosis with sirolimus-eluting stents.
    Li SS; So YC; Wong CH; Yiu SF; Chan KT
    J Invasive Cardiol; 2004 Feb; 16(2):81-3. PubMed ID: 14760198
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sirolimus- versus paclitaxel-eluting stent implantation for unprotected left main coronary artery stenosis.
    Lee SH; Ko YG; Jang Y; Kwon HM; Lee SH; Yoon JH; Park SH; Kim BO; Jeon DW; Yang JY; Ryu SK;
    Cardiology; 2005; 104(4):181-5. PubMed ID: 16155390
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-Term Clinical Outcomes After Bioresorbable Vascular Scaffold Implantation for the Treatment of Coronary In-Stent Restenosis: A Multicenter Italian Experience.
    Moscarella E; Ielasi A; Granata F; Coscarelli S; Stabile E; Latib A; Cortese B; Tespili M; Tanaka A; Capozzolo C; Caliendo L; Colombo A; Varricchio A
    Circ Cardiovasc Interv; 2016 Apr; 9(4):e003148. PubMed ID: 27059683
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Paclitaxel-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the TAXUS V ISR randomized trial.
    Stone GW; Ellis SG; O'Shaughnessy CD; Martin SL; Satler L; McGarry T; Turco MA; Kereiakes DJ; Kelley L; Popma JJ; Russell ME;
    JAMA; 2006 Mar; 295(11):1253-63. PubMed ID: 16531618
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Routine sirolimus eluting stent implantation for unselected in-stent restenosis: insights from the rapamycin eluting stent evaluated at Rotterdam Cardiology Hospital (RESEARCH) registry.
    Saia F; Lemos PA; Arampatzis CA; Hoye A; Degertekin M; Tanabe K; Sianos G; Smits PC; van der Giessen WJ; de Feyter PJ; van Domburg RT; Serruys PW
    Heart; 2004 Oct; 90(10):1183-8. PubMed ID: 15367519
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sirolimus-versus paclitaxel-eluting stents: a comparison of two consecutive series in routine clinical practice.
    Katritsis DG; Korovesis S; Karabinos I; Giazitzoglou E; Theodorou S; Karvouni E; Voridis E
    J Interv Cardiol; 2006 Feb; 19(1):31-7. PubMed ID: 16483337
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis: the three-year results of the PEPCAD II ISR study.
    Unverdorben M; Vallbracht C; Cremers B; Heuer H; Hengstenberg C; Maikowski C; Werner GS; Antoni D; Kleber FX; Bocksch W; Leschke M; Ackermann H; Boxberger M; Speck U; Degenhardt R; Scheller B
    EuroIntervention; 2015 Dec; 11(8):926-34. PubMed ID: 25169589
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictors of restenosis after treatment of bifurcational lesions with paclitaxel eluting stents: a multicenter prospective registry of 150 consecutive patients.
    Di Mario C; Morici N; Godino C; Goktekin O; Tamburino C; Barbagallo R; Antoniucci D; Grube E; Airoldi F; Zoccai GB; Colombo A; Sangiorgi GM
    Catheter Cardiovasc Interv; 2007 Feb; 69(3):416-24. PubMed ID: 17191238
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical outcome of percutaneous treatment of in-stent restenosis with drug-eluting stents: results from the first phase of the prospective multicentre German DES.DE registry.
    Abdel-Wahab M; Nienaber CA; Mostafa AE; Sabin G; Tebbe U; Hochadel M; Senges J; Akin I; Kuck KH; Hamm C; Richardt G;
    EuroIntervention; 2011 Jun; 7(2):201-8. PubMed ID: 21646062
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug-eluting stents for the treatment of in-stent restenosis--'real world' double centre experience in consecutive patients.
    Anderson RA; Fath-Ordoubadi F; Younas S; Bainbridge A; Swallow RA; Dawkins KD; Curzen NP
    Int J Cardiovasc Intervent; 2005; 7(4):188-92. PubMed ID: 16373265
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of diabetes mellitus on angiographic and clinical outcomes in the drug-eluting stents era.
    Yang TH; Park SW; Hong MK; Park DW; Park KM; Kim YH; Han KH; Lee CW; Cheong SS; Kim JJ; Park SJ
    Am J Cardiol; 2005 Nov; 96(10):1389-92. PubMed ID: 16275184
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of sirolimus-eluting coronary stents in routine clinical practice.
    Goy JJ; Urban P; Seydoux C; De Benedetti E; Stauffer JC
    Catheter Cardiovasc Interv; 2004 May; 62(1):26-9; discussion 62. PubMed ID: 15103595
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Contemporary treatment of in-stent restenosis and the incidence of recurrent in-stent restenosis in the era of drug-eluting stents.
    Ajani AE; Yan BP; Clark DJ; Eccleston D; Walton A; Lew R; Meehan A; Brennan A; Reid C; Duffy SJ;
    Heart Lung Circ; 2007 Aug; 16(4):269-73. PubMed ID: 17419097
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TAXUS III Trial: in-stent restenosis treated with stent-based delivery of paclitaxel incorporated in a slow-release polymer formulation.
    Tanabe K; Serruys PW; Grube E; Smits PC; Selbach G; van der Giessen WJ; Staberock M; de Feyter P; Müller R; Regar E; Degertekin M; Ligthart JM; Disco C; Backx B; Russell ME
    Circulation; 2003 Feb; 107(4):559-64. PubMed ID: 12566366
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Paclitaxel-eluting balloon versus everolimus-eluting stent for treatment of drug-eluting stent restenosis.
    Almalla M; Schröder J; Pross V; Marx N; Hoffmann R
    Catheter Cardiovasc Interv; 2014 May; 83(6):881-7. PubMed ID: 23765557
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incidence and predictors of recurrent restenosis following implantation of drug-eluting stents for in-stent restenosis.
    Lee CW; Park CB; Kim YH; Hong MK; Kim JJ; Park SW; Park SJ
    Catheter Cardiovasc Interv; 2007 Jan; 69(1):104-8. PubMed ID: 17139669
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical and angiographic outcomes after overdilatation of undersized sirolimus-eluting stents with largely oversized balloons: an observational study.
    Saia F; Lemos PA; Arampatzis CA; Hoye A; McFadden E; Sianos G; Smits PC; van der Giessen WJ; de Feyter PJ; van Domburg RT; Serruys PW
    Catheter Cardiovasc Interv; 2004 Apr; 61(4):455-60. PubMed ID: 15065137
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stent fracture associated with drug-eluting stents: clinical characteristics and implications.
    Lee MS; Jurewitz D; Aragon J; Forrester J; Makkar RR; Kar S
    Catheter Cardiovasc Interv; 2007 Feb; 69(3):387-94. PubMed ID: 17195203
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Description of Pantera Lux paclitaxel-releasing balloon and preliminary quantitative coronary angiography (QCA) results at six months in patients with coronary in-stent restenosis.
    Hehrlein C; Richardt G; Wiemer M; Schneider H; Naber C; Hoffmann E; Dietz U
    EuroIntervention; 2011 May; 7 Suppl K():K119-24. PubMed ID: 22027721
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Treatment of Paclitaxel-eluting stent restenosis with sirolimus-eluting stent implantation: angiographic and clinical outcomes].
    Byrne R; Iijima R; Mehilli J; Pache J; Schulz S; Schömig A; Kastrati A
    Rev Esp Cardiol; 2008 Nov; 61(11):1134-9. PubMed ID: 19000488
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.